Haemonetics (HAE) Non-Current Assets (2010 - 2026)

Haemonetics' Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.6 billion for Q1 2026.

• On a quarterly basis, Non-Current Assets rose 2.97% year-over-year to $1.6 billion in Q1 2026; TTM through Mar 2026 was $6.2 billion, a 0.43% change from a year earlier, with the FY2026 full-year figure at $1.6 billion, up 2.97% from the prior year.
• Non-Current Assets improved to $1.6 billion in Q1 2026 per HAE's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Non-Current Assets topped out at $1.6 billion in Q3 2024 and bottomed at $1.1 billion in Q1 2022.
• The 5-year median for Non-Current Assets is $1.4 billion (2023), against an average of $1.4 billion.
• Biggest YoY gain for Non-Current Assets was 69.6% in 2022; the steepest drop was 2.01% in 2022.
• Year by year, Non-Current Assets stood at $1.2 billion in 2022, then advanced by 22.5% to $1.4 billion in 2023, then increased by 6.27% to $1.5 billion in 2024, then increased by 1.43% to $1.5 billion in 2025, then grew by 0.89% to $1.6 billion in 2026.
• Per Business Quant, the three latest HAE Non-Current Assets figures stand at $1.6 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025).